April 12 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS: USE OF PROBUPHINE™ FOR OPIOID DISORDER GAINS MOMENTUM ACROSS CANADA; SUBDERMAL IMPLANT NOW IN USE FROM COAST TO COAST
* KNIGHT THERAPEUTICS - KNIGHT HAS EXCLUSIVE RIGHT TO DISTRIBUTE PROBUPHINE IN CANADA UNDER LICENSE AGREEMENT WITH TITAN PHARMACEUTICALS, INC